Emmanuel Macron says the government has “the instruments to guarantee” France’s supply

Emmanuel Macron said Monday that the government had “the instruments to guarantee that France is protected” faced with the anticipated arrival of a new American shareholder in an entity of the Sanofi group marketing Doliprane, relaunching the debate on the risks for the country’s supply of medicines.

“We fought so that Doliprane was reproduced in France and that we reproduce molecules and drugs which are essential”declared the Head of State on the sidelines of a trip to the Paris Motor Show. “And then there is capital ownership. And there, the government has the instruments to guarantee that France is protected”he assured.

Also read
Doliprane: the government is pushing to obtain commitments on French employment and supplies

“It is about the sovereignty of our country”

Antoine Armand and Marc Ferracci, the Minister of the Economy and his Minister for Industry are visiting Lisieux, the factory where Sanofi produces its famous Doliprane. Last week, the French laboratory announced its intention to sell Opella, its non-prescription medicines business, to the American fund CD&R. Among them are four drugs deemed strategic by the State, including Doliprane.

«Doliprane will continue to be produced in France, a promis Antoine Armand. Not only because it is a drug favored by all French people, not only because it is an industrial success but because the sovereignty of our country and also our supply of sensitive and critical drugs are at stake. “.